Stay updated on UC-961 in Relapsed CLL Clinical Trial

Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record provides details about the completed Phase 1 cirmtuzumab study for relapsed or refractory chronic lymphocytic leukemia, including its eligibility criteria, treatment cohorts, outcomes, and posted results and documents.
    Difference
    59%
    Check dated 2026-11-07T15:25:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:10:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:33:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.0 to v3.7.1. The study record remains unavailable on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-10T22:01:07.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the trial details and navigation with an error screen; users can no longer view the underlying information for that ClinicalTrials.gov entry.
    Difference
    20%
    Check dated 2026-09-19T18:56:04.000Z thumbnail image

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.